Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 29, 2024Journal of Pharmacy Practice

Evaluation of Tacrolimus Concentrations and Clinical Outcomes Between Extended and Immediate Release Formulations in Kidney Transplant

View Full Paper
Ask AI
Bookmark
Share

Authors

HNHannah NaguibGKGoni Katz‐GreenbergMHMatt Harris

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Naguib et al. (2024) studied this question.

synapsesocial.com/papers/68e6d190b6db64358764eddahttps://doi.org/10.1177/08971900241248862
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Early outcomes associated with de novo once‐daily extended‐release versus twice‐daily immediate‐release tacrolimus in a predominantly African American kidney transplant population: A single‐center observational study2024
  2. 2Extended-Release Tacrolimus Versus LifeCycle Pharma Tacrolimus in Kidney Transplant Recipients: A Switch Study2026
  3. 3The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report2024 · 2 citations
  4. 4New-Onset Diabetes After Transplantation in Renal Recipients: A Pilot Comparative Study of Immediate vs. Extended-Release Tacrolimus Formulation2025 · 1 citations
  5. 5Comparing the Effectiveness of Different Tacrolimus-Containing Medications Used in Daily Patient Care of Adult Kidney Transplant Patients in Transplant Centres of Eastern Hungary in a Prospective Non-Interventional Study (DeSz Study)2026